Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
We have investigated the transcriptomic and/or proteomic patterns of 71 solute carrier (SLC) and organic solute (OST) transporters, 34 ATP-binding cassette (ABC) transporters, and 51 metabolizing enzymes in human brain microvessels. We used quantitative RT-PCR and LC-MS/MS to examine isolated brain microvessels and cortex biopsies from 12 patients with epilepsia or glioma. SLC2A1/GLUT1, SLC1A3/EAAT1, and SLC1A2/EAAT2 were the main SLC proteins whereas ABCG2/BCRP, ABCB1/MDR1, ABCA2 and ABCA8 were the main ABC quantified in isolated brain microvessels; ABCG2/BCRP was 1.6-fold more expressed than ABCB1/MDR1, and ABCC4/MRP4 was 10 times less abundant than ABCB1/MDR1. CYP1B1 and CYP2U1 were the only quantifiable CYPs. Finally, GSTP1, COMT, GSTM3, GSTO1 and GSTM2 proteins were the main phase II enzymes quantified; UGTs and NATs were not detected. Our extensive investigation of gene and protein patterns of transporters and metabolizing enzymes provides new molecular information for understanding drug entry and metabolism in the human blood-brain barrier.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most efforts to combine transcriptomic and proteomic profiling have compared or validated the expression of genes via the abundance of their RNAs and proteins, including characterisation of abundance across healthy tissues45, changes due to neurological disorders46, and localised expression in neuronal processes47.”
From Decoding neuroproteomics: integrating the genome, translatome and functional anatomy (2014) · cites this paper as [46]
Citations
Cites
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279
Hediger, M. A., Romero, M. F., Peng, J.-B., Rolfs, A., Takanaga, H., & Bruford, E. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1192-y · Cited by 985
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Uchida, Y., Ohtsuki, S., Katsukura, Y., Ikeda, C., Suzuki, T., Kamiie, J., & Terasaki, T. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07208.x · Cited by 881
Self-citationBlood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.86 · Cited by 872
Kamiie, J., Ohtsuki, S., Iwase, R., Ohmine, K., Katsukura, Y., Yanai, K., Sekine, Y., Uchida, Y., Ito, S., & Terasaki, T. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9532-4 · Cited by 478
Self-citationTransporting therapeutics across the blood-brain barrier
Abbott, N. J., & Romero, I. A. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88720-x · Cited by 447
Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)
Lee, W., Glaeser, H., Smith, L. H., Roberts, R. L., Moeckel, G. W., Gervasini, G., Leake, B. F., & Kim, R. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411092200 · Cited by 365
Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human
Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060194 · Cited by 351
Research works printed but not linked: 3
- Hagenbuch B., 2002, News Physiol. Sci., 17, 231
- Martinasevic M. K., 1998, Drug Metab. Dispos., 26, 1039
- Cornford E. M., 1992, Cancer Res., 52, 138
Cited by
Items 201–300 of 400
Mitochondrial cytochrome P450 1B1 is involved in pregnenolone synthesis in human brain cells
Lin, Y. C., Cheung, G., Zhang, Z., & Papadopoulos, V. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105035 · Cited by 25
Computational modeling to predict the functions and impact of drug transporters
Matsson, P., & Bergström, C. A. S. (2015) · In Silico Pharmacology · doi:10.1186/s40203-015-0012-3 · Cited by 25
“Conflicting results were reported for BCRP where The Human Protein Atlas showed low expression whereas significant amount of protein was observed by Shawahna et al. (2011) a MDR1 is also known as Pgp even before the compound is synthesized.”
ResultBicker, J., Fortuna, A. C., Alves, G., Soares-da-Silva, P., & Falcão, A. C. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.077883 · Cited by 26
“Additionally, it was found that the expression of BCRP is more prominent in humans than that of P-gp (Shawahna et al., 2011), whereas P-gp is more abundantly expressed in rodents (Kamiie et al.”
BackgroundKooijmans, S. A. A., Senyschyn, D., Mezhiselvam, M. M., Morizzi, J., Charman, S. A., Weksler, B. B., Romero, I. A., Couraud, P., & Nicolazzo, J. A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2004127 · Cited by 24
Self-citationSheng, Y., Yang, H., Wu, T., Zhu, L., Liu, L., & Liu, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.650027 · Cited by 24
“Moreover, in freshly isolated human brain microvasculature, only CYP1B1 and CYP2U1 could be quantified among the investigated 21 CYPs (Shawahna et al., 2011).”
BackgroundExploring ITM2A as a new potential target for brain delivery
Cegarra, C., Chaves, C., Déon, C., Do, T. M., Dumas, B., Frenzel, A., Kuhn, P., Roudières, V., Guillemot, J.-C., & Lesuisse, D. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00321-3 · Cited by 25
Mehta, A., Desai, A., Rudd, D. A., Siddiqui, G., Nowell, C. J., Tong, Z., Creek, D. J., Tayalia, P., Gandhi, P. S., & Voelcker, N. H. (2022) · Advanced Biology · doi:10.1002/adbi.202200152 · Cited by 25
Feteisi, H. A., Achour, B., Rostami‐Hodjegan, A., & Barber, J. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1055245 · Cited by 27
“Considering the large amounts of data generated by quantitative proteomics for different pharmacokinetically relevant systems (including the liver [14,22,26-30,32-40], kidneys [32,90], lungs [91], intestine [23,24,32,36,42] and the blood--brain barrier [31,41]), there is a clear need to assess how these data can be sy…”
BackgroundMethodJacob, A., Potin, S., Chapy, H., Crété, D., Glacial, F., Ganeshamoorthy, K., Couraud, P., Scherrmann, J., & Declèves, X. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.049 · Cited by 24
Self-citationLiu, H., Huang, L., Li, Y., Fu, T., Sun, X., Zhang, Y., Gao, R., Chen, Q., Zhang, W., Sahi, J., et al. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074245 · Cited by 26
“…Uchida et al. (2013);Agarwal et al. (2012) Rat (Sprague Dawley) 4.15 3.30 0.30 Hoshi et al. (2013); Fuchs et al. (2014) Human 6.15, 8.14 (mean 7.15) 9.1 (predicted)b 0.10 Shawahna et al. (2011); Uchida et al. (2011b) aThe Kp,uu value was predicted by the reciprocal of the ERin vivo value (eq.”
InfluentialQuantitative Targeted Proteomics for Membrane Transporter Proteins: Method and Application
Qiu, X., Zhang, H., & Lai, Y. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9607-6 · Cited by 23
Auvity, S., Chapy, H., Goutal, S., Caillé, F., Hosten, B., Smirnova, M., Declèves, X., Tournier, N., & Cisternino, S. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16662042 · Cited by 23
“N,N-dimethylethanamine) is a clinically approved histamine H1-receptor (H1R) antagonist with known sedative effects.8 In situ brain perfusion experiments have shown a saturable uptake transport mechanism for diphenhydramine at the rat BBB.9 Recent brain microdialysis experiments have also suggested the importance of d…”
BackgroundSelf-citationYu, X., Wu, J., Hu, M.-B., Wu, J., Zhu, Q., Yang, Z., Xie, X., Feng, Y., & Yue, J. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.03.001 · Cited by 23
Puris, E., Saveleva, L., Maciel, I. D. S., Kanninen, K. M., Auriola, S. O. K., & Fricker, G. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03111-y · Cited by 25
“Although ASCT1 protein expression was reported in the isolated human brain microvessels [55], capillary endothelial cells of embryonic and neonatal mouse brains [52], and rodent astrocytes and neurons [51, 56, 57], alterations in ASCT1 expression and function in the NVU cells in AD patients have not been investigated.”
BackgroundThe role of brain barriers in the neurokinetics and pharmacodynamics of lithium
Luo, H., Chevillard, L., Bellivier, F., Mégarbane, B., Étain, B., Cisternino, S., & Declèves, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105480 · Cited by 22
Self-citationBreuil, L., Marie, S., Goutal, S., Auvity, S., Truillet, C., Saba, W., Langer, O., Caillé, F., & Tournier, N. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211045444 · Cited by 22
“Differences in P-gp expression at the BBB have been reported between humans and rodents.(47,48) Moreover, many compounds show disparate P-gp-mediated transport between human and rodent P-gp in vitro.”
Glutamate Transporters in the Blood-Brain Barrier
Helms, H. C. C., Nielsen, C. U., Waagepetersen, H. S., & Brodin, B. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-55769-4_15 · Cited by 22
“Large quantities of EAAT1 mRNA (Shawahna et al. 2011) were found in human brain capillaries.”
BackgroundVeszelka, S., Mészáros, M., Porkoláb, G., Szecskó, A., Kondor, N., Ferenc, G., Polgár, T. F., Katona, G., Kóta, Z., Kelemen, L., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010086 · Cited by 22
“Leucine is an essential amino acid used in the biosynthesis of proteins, which is transported by LAT1, an amino acid transporting SLC, showing a very high gene expression level in human brain microvessels [43]—about 100-fold higher than in peripheral microvessels.”
BackgroundContributions of Drug Transporters to Blood-Brain Barriers
Liu, L., & Liu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_9 · Cited by 22
Chatterjee, S., Deshpande, A. A., & Shen, H. (2023) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2345 · Cited by 24
PBPK modeling of irbesartan: incorporation of hepatic uptake
Chapy, H., Klieber, S., Brun, P., Gerbal‐Chaloin, S., Boulenc, X., & Nicolas, O. (2015) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1961 · Cited by 21
Andrés‐Benito, P., Domínguez-González, M., & Ferrer, I. (2018) · Prion · doi:10.1080/19336896.2018.1500076 · Cited by 21
“endothelial cells, including brain microvessels [48,49].”
Chen, E. C., Matsson, P., Azimi, M., Zhou, X., Handin, N., Yee, S. W., Artursson, P., & Giacomini, K. M. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03171-8 · Cited by 21
Hau, R. K., Wright, S. H., & Cherrington, N. J. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2984 · Cited by 21
The ABCG2 Multidrug Transporter
Basseville, A., Hall, M. D., Chau, C. H., Robey, R. W., Gottesman, M. M., Figg, W. D., & Bates, S. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-23476-2_9 · Cited by 25
Opioid-Mediated HIV-1 Immunopathogenesis
Buch, S. J., Periyasamy, P., Thangaraj, A., Sil, S., Chivero, E. T., & Tripathi, A. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09960-5 · Cited by 20
Role of the efflux transporters Abcb1 and Abcg2 in the brain distribution of olaparib in mice
Song, Y.-K., Kim, M.-J., Kim, M., Lee, J. H., Chung, S., Song, J. S., Chae, Y., & Lee, K. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106177 · Cited by 21
Zhang, W., Oh, J.-H., Zhang, W., Rathi, S., Le, J., Talele, S., Sarkaria, J. N., & Elmquist, W. F. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03574-1 · Cited by 19
“In human brain microvessels, P-gp and BCRP are dominant ABC transporters, and BCRP protein expression is higher than that of P-gp (almost two fold), while MRP4 has much less expression [84, 85].”
The Impact of P‐Glycoprotein on CNS Drug Efflux and Variability in Response
Paul, P. R., Mishra, M., Bora, S., Kukal, S., Singh, A., Kukreti, S., & Kukreti, R. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70190 · Cited by 19
Wu, J., Li, Y., Tian, S., Na, S., Wei, H., Wu, Y., Yang, Y., Shen, Z., Ding, J., Bao, S., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14633 · Cited by 19
“11,12 β - catenin signaling is crucial for the development and maintenance of cerebral blood vessels, 13 while CYP1B1 was signifi - cantly decreased in endothelial cells with β - catenin deficiency.”
BackgroundToselli, F., Depaz, I., Worrall, S., Etheridge, N., Dodd, P. R., Wilce, P. A., & Gillam, E. M. J. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12697 · Cited by 20
Dhers, L., Pietrancosta, N., Ducassou, L., Ramassamy, B., Dairou, J., Jaouen, M., André, F., Mansuy, D., & Boucher, J. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.07.018 · Cited by 19
Wong, Y. C., Centanni, M., & de Lange, E. C. M. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1365 · Cited by 20
Gomez‐Zepeda, D., Chaves, C., Taghi, M., Sergent, P., Liu, W., Chhuon, C., Vidal, M., Picard, M., Thioulouse, E., Broutin, I., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14095 · Cited by 19
Self-citationChaves, C., Do, T.-M., Cegarra, C., Roudières, V., Tolou, S., Thill, G., Rocher, C., Didier, M., & Lesuisse, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100967 · Cited by 19
“These findings are consistent with reported transcriptomic and proteomic analyses [10,57,78], and evidence that ABCG2 greater expression over ABCB1 prevails among the primate BBB.”
ResultGantner, M. E., Ianni, M. E. D., Ruiz, M. E., Talevi, A., & Bruno‐Blanch, L. E. (2013) · BioMed Research International · doi:10.1155/2013/863592 · Cited by 20
“Hindawi Publishing Corporation BioMed Research International Volume 2013, Article ID 863592, 12 pages http://dx.doi.org/10.1155/2013/863592”
InfluentialSato, R., Ohmori, K., Umetsu, M., Takao, M., Tano, M., Grant, G. A., Porter, B. E., Bet, A., Terasaki, T., & Uchida, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122122 · Cited by 18
“In this study, we applied the SWATH method, which has excellent specificity and quantitative accuracy, and for the first time we were able to accurately quantify the expression levels of MDR1 and BCRP.”
BackgroundSelf-citationGenetics of Cholesterol Efflux
Iatan, I., Palmyre, A., Alrasheed, S., Ruel, I. L., & Genest, J. J. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0247-y · Cited by 20
“The protein has been isolated in human brain microvessels [72] where it could play a role in intracellular lipid trafficking rather than trans-plasma membrane transport [73].”
BackgroundAssessing central nervous system drug delivery
Hammarlund‐Udenaes, M., & Loryan, I. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2462767 · Cited by 17
Metabolite transport across central nervous system barriers
Carstens, G., Verbeek, M. M., Rohlwink, U. K., Figaji, A., Brake, L. T., & van Laarhoven, A. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241241908 · Cited by 17
Lack of CAR impacts neuronal function and cerebrovascular integrity in vivo
Boussadia, B., Gangarossa, G., Mselli-Lakhal, L., Rousset, M.-C., de Bock, F., Lassere, F., Ghosh, C., Pascussi, J., Janigro, D., & Marchi, N. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.018 · Cited by 18
“A detailed procedure is described in Shawahna et al. (2011).”
Hashimoto, Y., Michiba, K., Maeda, K., & Kusuhara, H. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.10.010 · Cited by 17
Achieving a Deeper Understanding of Drug Metabolism and Responses Using Single-Cell Technologies
Wheeler, A. M., Eberhard, C. D., Mosher, E. P., Yuan, Y., Wilkins, H. N., Seneviratne, H. K., Orsburn, B. C., & Bumpus, N. N. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001043 · Cited by 16
“Regarding phase 2 metabolizing enzymes, UGTs and NATs were not observed in the microvasculature of the BBB, but SULT1A1 was expressed (Shawahna et al., 2011).”
BackgroundPinto, M., Fernandes, C., Gil-Martins, E., Silva, R. V. D. S., Benfeito, S., Cagide, F., Mendes, R. F., Paz, F. A. A., Garrido, J., Remião, F., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11070331 · Cited by 17
“The intracellular localization of PEGylated PCL NPs was verified by fluorescence microscopy in neuronal and endothelial (SH-SY5Y and hCMEC/D3) cells that express MAO-B [56,57].”
Mann, A., Billington, S. F., Benifla, M., Nguyen, T. B., Han, H., Bennet-Back, O., Gilboa, T., Blatch, D., Fellig, Y., Volkov, O., et al. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00083 · Cited by 16
Qian, S., Wang, Q., & Zuo, Z. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.956080 · Cited by 18
“Glutathione S-transferases P1, M3, O1 and M2 and COMT were the main Phase II enzymes in human brain, whereas uridine diphosphate-glucuronosyltransferases and N-acetyltransferases were not found [23].”
BackgroundCouyoupetrou, M., Gantner, M. E., Ianni, M. E. D., Palestro, P. H., Enrique, A., Gavernet, L., Ruiz, M. E., Pesce, G. O., Bruno‐Blanch, L. E., & Talevi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161013103408 · Cited by 17
“It is also relevant to note that proteomics studies have shown ABCG2 as the transporter with highest basal expression levels at the BBB of healthy subjects [57, 58], which underlines the convenience of assessing recognition by other ABC transporters apart from Pgp when designing novel AEDs.”
BackgroundBrain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences
Bourasset, F., Auvity, S., Thorne, R. G., & Scherrmann, J. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_402 · Cited by 16
Self-citationBlood–Brain Barrier Proteomics: Towards the Understanding of Neurodegenerative Diseases
Karamanos, Y., Gosselet, F., Dehouck, M., & Cecchelli, R. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.008 · Cited by 15
“An extensive investigation of gene and protein patterns of transporters and metabolizing enzymes carried out on isolated brain microvessels and cortex biopsies from 12 patients with epilepsy or glioma provided molecular information for understanding drug entry and metabolism in the human BBB (44).”
Insights Into Translatomics in the Nervous System
Zhang, S., Chen, Y., Wang, Y., Zhang, P., Chen, G., & Zhou, Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.599548 · Cited by 16
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine
Hermann, R., Krajcsi, P., Fluck, M., Seithel‐Keuth, A., Bytyqi, A. H., Galazka, A. R., & Munafo, A. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01065-3 · Cited by 16
Zhou, X., Azimi, M., Handin, N., Riselli, A. M., Vora, B., Chun, E., Dang, Z., Huang, E. J., Yee, S. W., Artursson, P., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-31224-6 · Cited by 15
“First, there is contamination of other brain cell types in our BMV samples, however, this type of potential contamination has been reported in other studies when characterizing the BBB (Supplemental Table 5 12,13 ,).”
Torres‐Vergara, P., Escudero, C., & Penny, J. I. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01502 · Cited by 15
Impact of Peptide Transport and Memory Function in the Brain
Cheng, L., Shi, C., Li, X., & Matsui, T. (2024) · Nutrients · doi:10.3390/nu16172947 · Cited by 13
Grabowska, A. D., Wątroba, M., Witkowska, J., Mikulska, A., Sepúlveda, N., & Szukiewicz, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411640 · Cited by 13
Role of (Drug) Transporters in Imaging in Health and Disease
Stieger, B., Unadkat, J. D., Prasad, B., Langer, O., & Gali, H. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059873 · Cited by 13
“To address this deficiency our laboratory (and others) now uses liquid chromatography–tandem mass spectrometry (LC-MS/MS) proteomics and surrogate peptides to quantify transporter-protein expression in tissues and cell lines (Li et al., 2009; Shawahna et al., 2011; Uchida et al., 2013; Prasad et al., 2014).”
MethodSivapackiam, J., Harpstrite, S. E., Prior, J. L., Mattingly, S., & Sharma, V. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.12.001 · Cited by 13
“6-fold lower than Pgp in human [17,18] andmurine [19,20] BBB, respectively.”
BackgroundDucassou, L., Dhers, L., Jonasson, G., Pietrancosta, N., Boucher, J., Mansuy, D., & André, F. (2017) · Biochimie · doi:10.1016/j.biochi.2017.07.007 · Cited by 13
Defects in Glutathione System in an Animal Model of Amyotrophic Lateral Sclerosis
Wunsch, F., Metzler‐Nolte, N., Theiß, C., & Matschke, V. (2023) · Antioxidants · doi:10.3390/antiox12051014 · Cited by 14
“In the hippocampus, qPCR revealed an upregulation of all analyzed genes involved in the transport of glutathione and its components in wobbler mice compared to wild-type mice (Figure 4a), whereas Western Blot analysis of MRP4 indicated an unaltered protein expression (Figure 4b). mRNA expression levels of genes involv…”
BackgroundInfluentialGoutal, S., Langer, O., Auvity, S., Andrieux, K., Coulon, C., Caillé, F., Gervais, P., Cisternino, S., Declèves, X., & Tournier, N. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0472-6 · Cited by 12
Self-citationTaccola, C., Barnéoud, P., Cartot‐Cotton, S., Valente, D., Schussler, N., Saubaméa, B., Chasseigneaux, S., Cochois, V., Mignon, V., Curis, E., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108588 · Cited by 13
Self-citationThe Function and Expression of ATP-Binding Cassette Transporters Proteins in the Alzheimer's Disease
Aykaç, A., & Sehirli, A. Ö. (2021) · Global Medical Genetics · doi:10.1055/s-0041-1735541 · Cited by 13
Mori, A., Masuda, T., Ito, S., & Ohtsuki, S. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03387-8 · Cited by 11
Self-citationPBPK Modeling Approach for Predictions of Human CNS Drug Brain Distribution
de Lange, E. C. M. (2015) · Wiley eBooks · doi:10.1002/9781118788523.ch14 · Cited by 14
Drug Transport and Metabolism in the Blood–Brain Barrier
Kapitulnik, J. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00037 · Cited by 11
“Using transcriptomics and proteomics approaches, the presence of these proteins has been demonstrated in isolated human brain microvessels and cortex biopsies (Shawahna et al., 2011).”
Meissner, K., Blood, J., Francis, A. M., Yermolenka, V., & Kharasch, E. D. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000391 · Cited by 11
Kanamitsu, K., Nozaki, Y., Nagaya, Y., Sugiyama, Y., & Kusuhara, H. (2016) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2016.11.007 · Cited by 11
Bor, G., & Hosta‐Rigau, L. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300161 · Cited by 11
Dang, H., Wang, J., Cheng, J., Wang, P., Wang, Y., Cheng, L., Du, C., & Wang, X. (2015) · Europe PMC (PubMed Central) · Cited by 10
Farina, F., Lonati, E., Brambilla, A., Magro, R. D., Milani, C., Botto, L., Sancini, G., Palestini, P., & Bulbarelli, A. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.04.003 · Cited by 10
Mass Spectrometry of Human Transporters
Achour, B., Al‐Majdoub, Z. M., Rostami‐Hodjegan, A., & Barber, J. (2020) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-091719-024553 · Cited by 11
“Key to obtaining good data is good sample preparation, beginning with the isolation of microvessels (35, 36).”
BackgroundJezierski, A., Huang, J., Haqqani, A. S., Haukenfrers, J., Liu, Z., Baumann, E., Sodja, C., Charlebois, C., Delaney, C. E., Star, A. T., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00437-0 · Cited by 9
“For example, TfR is threefold more abundant in rodent compared to human brain vessels [1, 3, 87, 88], underscoring the importance of species relevant BBB models that replicate in vivo species differences.”
BackgroundIn Vitro Human Blood-Brain Barrier Model for Drug Permeability Testing
Bayır, E., & Şendemir, A. (2021) · Methods in molecular biology · doi:10.1007/7651_2020_344 · Cited by 9
Moorthy, N. K., Seifert, O., Eisler, S. A., Weirich, S., Kontermann, R. E., Rehm, M., & Fullstone, G. (2021) · Molecules · doi:10.3390/molecules26247582 · Cited by 10
Al‐Qadi, S., Schiøtt, M., Hansen, S. H., Nielsen, P. A., & Badolo, L. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.09.002 · Cited by 9
“This is attributed to the interplay among molecular components including the metabolizing enzymes and tight junctions which endow high electrical resistance precluding paracellular entry to the brain and, more importantly, the ATP-driven efflux transporters that are viewed as the major hurdle to central nervous system…”
BackgroundInfluentialRetinal and choroidal cancers: Blood-retinal barriers considerations in ocular chemotherapy
Matet, A., Béhar‐Cohen, F., Cassoux, N., Declèves, X., & Cisternino, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816434-1.00010-3 · Cited by 13
Self-citationLuo, H., Declèves, X., & Cisternino, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030334 · Cited by 8
“Some nutrients and/or xenobiotics transporters from the solute carrier (SLC) superfamily are also specifically expressed in the BBB, allowing transcellular transport of substrates to the brain such as glucose, amino acids, or drugs [5,6].”
BackgroundSelf-citationVollmuth, N., Sin, J., & Kim, B. J. (2024) · mBio · doi:10.1128/mbio.02862-23 · Cited by 10
Tóth, M., Häggkvist, J., Varrone, A., Finnema, S. J., Doorduin, J., Tokunaga, M., Higuchi, M., Gulyás, B. Z., & Halldin, C. (2014) · EJNMMI Research · doi:10.1186/s13550-014-0064-0 · Cited by 8
“In humans, however, it has been found that Bcrp has a higher expression level than P-gp [8].”
BackgroundThe Blood–Brain Barrier: An Introduction to Its Structure and Function
Mahringer, A., Ott, M., & Fricker, G. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_20 · Cited by 11
Using miniature brain implants in rodents for novel drug discovery
Waldau, B. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1577816 · Cited by 8
Lin, Y. C., & Papadopoulos, V. (2024) · Steroids · doi:10.1016/j.steroids.2024.109521 · Cited by 7
Gomez‐Zepeda, D., Perrière, N., Glacial, F., Taghi, M., Chhuon, C., Scherrmann, J., Sergent, P., Moreau, A., Denizot, C., Parmentier, Y., et al. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116456 · Cited by 7
Self-citationLitjens, C. H. C., Verscheijden, L. F. M., Svensson, E. M., van den Broek, P. H. H., van Hove, H., Koenderink, J. B., Rüssel, F. G. M., Aarnoutse, R. E., & Brake, L. H. M. T. (2023) · Antibiotics · doi:10.3390/antibiotics12040702 · Cited by 7
Dong, J., Mao, J., Wu, W., Qian, X., & Yu, Z. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04334-w · Cited by 7
Taccola, C., Cartot‐Cotton, S., Valente, D., Barnéoud, P., Aubert, C., Boutet, V., Gallen, F., Lochus, M., Nicolic, S., Dodacki, A., et al. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.02.005 · Cited by 7
Self-citationRostami‐Hodjegan, A., & Achour, B. (2023) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-29541-6_6 · Cited by 7
Drug Metabolism at the Blood–Brain and Blood–CSF Barriers
Declèves, X., Strazielle, N., Scherrmann, J., & Ghersi‐Egea, J. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-9105-7_4 · Cited by 8
Self-citationFunctional Characteristics of Brain Tumor Vascularization
Wilhelm, I., & Krizbai, I. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00134-2 · Cited by 7
Łapczuk-Romańska, J., Wajda, A., Pius‐Sadowska, E., Kurzawski, M., Niedzielski, A., Machaliński, B., & Droździk, M. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.03.008 · Cited by 7
In Vitro Characterization of Interactions with Drug Transporting Proteins
Artursson, P., Matsson, P., & Karlgren, M. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-8229-1_3 · Cited by 7
“Significant interspecies differences have recently been observed for transport proteins expressed in the BBB of various mammals, including humans (Shawahna et al. 2011).”
BackgroundDesigning Peripheral Drugs for Minimal Brain Exposure
Bungay, P. J., Bagal, S. K., & Pike, A. (2015) · Wiley eBooks · doi:10.1002/9781118788523.ch20 · Cited by 9
Ali, A., Touboul, D., Caër, J. L., Schmitz, I., Flinois, J.-P., Marchetti, C., de Waziers, I., Brunelle, A., Laprévôte, O., & Beaune, P. H. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7928-z · Cited by 6
“This approach was also used to quantify some abundant isoforms in particular tissues, such as CYP2U1 and CYP1B1 in human brain microvessels [25].”
Jacob, A., Declèves, X., & Scherrmann, J. (2012) · Biologie Aujourd hui · doi:10.1051/jbio/2012022 · Cited by 6
Self-citationCegarra, C., Cameron, B., Chaves, C., Dabdoubi, T., Do, T.-M., Genêt, B., Roudières, V., Shi, Y. Y., Tchepikoff, P., & Lesuisse, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274667 · Cited by 7
The brain in flux: Genetic, physiologic, and therapeutic perspectives on transporters in the CNS
Blakely, R., Mestikawy, S. E., & Robinson, M. B. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.12.006 · Cited by 6
Gülave, B., Lesmana, A., de Lange, E. C. M., & van Hasselt, J. G. C. (2025) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-024-09957-0 · Cited by 6
Strazielle, N., Silva, K., Rault, E., Durand, C., Saudrais, É., Mein, P., Blondel, S., Denuzière, A., & Ghersi‐Egea, J. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00622-3 · Cited by 5
“The expression of some GST isoforms, mainly GST pi1, has also been described in cerebral capillaries isolated from adult humans and developing and adult rats, albeit at lower levels than in the choroid plexus [11, 33].”
Puris, E., Saveleva, L., Auriola, S. O. K., Gynther, M., Kanninen, K. M., & Fricker, G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1365051 · Cited by 5
Anatomy and Physiology of the Blood-Brain Barriers*
Abbott, N. J. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_1 · Cited by 9
Metadata
- Authors
- Shawahna, R., Uchida, Y., Declèves, X., Ohtsuki, S., Yousif, S., Dauchy, S., Jacob, A., Chassoux, F., Daumas-Duport, C., Couraud, P.-O., Terasaki, T., & Scherrmann, J.-M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Tohoku University (JP)
- Centre Hospitalier Sainte-Anne (FR)
- Ste Anne Hospital, Paris, France
- Inserm (FR)
- Corresponding author
- Declèves, Xavier
- ORCID
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-07-08
- Volume
- 8
- Issue
- 4
- Pages
- 1332-1341
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W2090945850
- Cited by
- 372
- References
- 48
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 23 · 2023: 19 · 2022: 27 · 2021: 26 · 2020: 31 · 2019: 20 · 2018: 30 · 2017: 29 · 2016: 29 · 2015: 35 · 2014: 27 · 2013: 32 · 2012: 24
- FWCI
- 13.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23790170)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- cerebral microvasculature, blood-brain barrier, solute carrier transporters, organic cation transporters, ABC transporters, drug-metabolizing enzymes, drug transporters, GLUT1, GLAST, GLT-1, MDR1/ABCB1, ABCA2, ABCA8, CYP1B1, CYP2U1, glutathione S-transferase, catechol-O-methyltransferase, glioma
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 2, Brain, Chromatography, Liquid, Glutathione Transferase, Humans, Neoplasm Proteins, ATP Binding Cassette Transporter, Subfamily B, ATP-Binding Cassette Transporters, ATP Binding Cassette Transporter, Subfamily B, Member 1, Excitatory Amino Acid Transporter 1, Excitatory Amino Acid Transporter 2, Proteomics, Glutamate Plasma Membrane Transport Proteins, Glucose Transporter Type 1, Glutathione S-Transferase pi, Tandem Mass Spectrometry, Microvessels, Transcriptome, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.